IDEXX Laboratories Inc.

NASDAQ: IDXX · Real-Time Price · USD
657.08
3.13 (0.48%)
At close: Aug 15, 2025, 10:14 AM

IDEXX Laboratories Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3.9B 3.66B 3.37B 3.22B
Cost of Revenue
1.52B 1.47B 1.36B 1.33B
Gross Profit
2.38B 2.19B 2B 1.89B
Operating Income
1.13B 1.1B 898.76M 932.03M
Interest Income
12.7M 5.63M 1.06M 434K
Pretax Income
1.11B 1.06B 859.97M 902.65M
Net Income
887.87M 845.04M 679.09M 744.85M
Selling & General & Admin
1.03B 901.89M 850.75M 796.39M
Research & Development
219.79M 190.95M 254.82M 161.01M
Other Expenses
n/a n/a 2.2M 1.46M
Operating Expenses
1.25B 1.09B 1.11B 957.4M
Interest Expense
31.2M 41.58M 39.86M 29.81M
Selling & Marketing Expenses
588.51M 566.07M 524.5M 486.74M
Cost & Expenses
2.77B 2.56B 2.47B 2.28B
Income Tax Expense
221.96M 216.13M 180.88M 157.81M
Shares Outstanding (Basic)
82.47M 83.07M 83.62M 85.2M
Shares Outstanding (Diluted)
83.25M 83.98M 84.6M 86.57M
EPS (Basic)
10.77 10.17 8.12 8.74
EPS (Diluted)
10.67 10.06 8.03 8.60
EBITDA
1.28B 1.22B 1.01B 1.04B
EBIT
1.14B 1.1B 899.83M 932.46M
Depreciation & Amortization
129.94M 114.91M 111.9M 104.6M